Aramark

ARMK · NYSE · Consumer Discretionary

$62.40▲ +2.12%

+$1.30 today

Mkt cap $14.30B
P/E 40.6
Day $61.51 – $62.65

Confidence

High conviction

The read

Aramark beat EPS estimates, but valuation and thin margins leave execution as the next test

Aramark reported $0.52 EPS for the quarter ended June 30, beating the $0.48 estimate by 8.3%. Shares rose 2.12% to $62.40 on August 14, while the event-day reaction was unavailable. Forward growth expectations support the thesis, but a 4.31% operating margin, 1.96 debt-to-equity ratio, and RSI of 85.65 raise execution and valuation risks.

Confidence note: Reported EPS and price data are available, but guidance values, post-earnings news, and event-window returns are unavailable.

What happened

Earnings print

Reported EPS was $0.52 versus the $0.48 estimate, a $0.04 or 8.3% beat, reported August 11 for the quarter ended June 30.

Guidance

The payload identifies raised-outlook follow-through as the catalyst, but provides no explicit guidance figures or quantified change.

Price reaction

The event-day, first-day, and second-day reactions were unavailable; shares were up 2.12% at $62.40 on August 14.

Street narrative

The post-earnings thesis emphasized accelerating profit growth, while the 4.31% operating margin and 1.96 debt-to-equity ratio kept execution and leverage as key risks.

So what

What changed

EPS was $0.52, beating estimates by 8.3%, while raised-outlook follow-through became the next catalyst.

What the market is pricing

A 2.12% share gain and 20.84 forward P/E indicate support for growth despite RSI reaching 85.65.

Fundamental takeaway

Maintain a constructive bias only if raised outlook converts into further earnings growth without margin deterioration.

Next 30–90 days

Bull

40%

The EPS beat and 19.69% next-year EPS growth forecast support continued rerating if management delivers on its raised outlook.

Management provides quantified raised-outlook follow-through.
Forward EPS expectations remain near the stated 19.69% next-year growth rate.

Base

35%

The beat supports earnings momentum, but a 41.81 trailing P/E and overbought RSI may limit near-term upside without additional guidance evidence.

The next company update preserves the raised outlook.
Shares consolidate while forward P/E remains near 20.84.

Bear

25%

A modest 4.31% operating margin and heavy leverage could amplify downside if revenue growth slows or costs rise.

Management reports margin deterioration from 4.31%.
Revenue growth weakens from the 10.15% TTM pace.

What to do

If you hold it

Hold unless the next quantified outlook update shows margin deterioration from 4.31% or materially lowers the 19.69% next-year EPS growth outlook.

If you're watching

Add only if raised-outlook follow-through is quantified and operating margin improves; do not trade if guidance remains unquantified while RSI stays at 85.65.

Add to Watchlist

Quantified raised-outlook follow-through in the next company update.
Operating margin versus the current 4.31% level.
Next-year EPS growth expectations versus 19.69%.
Debt-to-equity and any management commentary around the current 1.96 ratio.